Universitair Ziekenhuis Leuven — Leuven

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Universitair Ziekenhuis Leuven, compiled from the ClinicalTrials.gov public registry.

259

Registered studies

127

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn Disease · Ovarian Cancer · Hemolytic Disease of the Fetus and Newborn · Squamous Cell Carcinoma of Head and Neck

Recently updated registry entries

NCT03105102 — A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (Active Not Recruiting)
NCT06570798 — A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases (Recruiting)
NCT07195916 — A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.